ID   DHAL_LACLA              Reviewed;         192 AA.
AC   Q9CIV7;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   22-JUL-2015, entry version 72.
DE   RecName: Full=PTS-dependent dihydroxyacetone kinase, ADP-binding subunit DhaL;
DE            EC=2.7.-.-;
GN   Name=dhaL; OrderedLocusNames=LL0249; ORFNames=L46694;
OS   Lactococcus lactis subsp. lactis (strain IL1403) (Streptococcus
OS   lactis).
OC   Bacteria; Firmicutes; Bacilli; Lactobacillales; Streptococcaceae;
OC   Lactococcus.
OX   NCBI_TaxID=272623;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=IL1403;
RX   PubMed=11337471; DOI=10.1101/gr.GR-1697R;
RA   Bolotin A., Wincker P., Mauger S., Jaillon O., Malarme K.,
RA   Weissenbach J., Ehrlich S.D., Sorokin A.;
RT   "The complete genome sequence of the lactic acid bacterium Lactococcus
RT   lactis ssp. lactis IL1403.";
RL   Genome Res. 11:731-753(2001).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 2-192 IN COMPLEX WITH ADP AND
RP   MAGNESIUM IONS, FUNCTION, AND MUTAGENESIS OF ARG-114; ARG-161 AND
RP   TYR-164.
RX   PubMed=18957416; DOI=10.1074/jbc.M804893200;
RA   Zurbriggen A., Jeckelmann J.M., Christen S., Bieniossek C.,
RA   Baumann U., Erni B.;
RT   "X-ray structures of the three Lactococcus lactis dihydroxyacetone
RT   kinase subunits and of a transient intersubunit complex.";
RL   J. Biol. Chem. 283:35789-35796(2008).
CC   -!- FUNCTION: ADP-binding subunit of the dihydroxyacetone kinase,
CC       which is responsible for phosphorylating dihydroxyacetone.
CC       {ECO:0000269|PubMed:18957416}.
CC   -!- PATHWAY: Polyol metabolism; glycerol degradation.
CC   -!- SUBUNIT: The dihydroxyacetone kinase complex is composed of a
CC       homodimer of DhaM, a homodimer of DhaK and the subunit DhaL.
CC       {ECO:0000269|PubMed:18957416}.
CC   -!- INDUCTION: Induced by dihydroxyacetone via the DhaQ-DhaS complex.
CC   -!- SIMILARITY: Contains 1 DhaL domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00813}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE005176; AAK04347.1; -; Genomic_DNA.
DR   PIR; A86656; A86656.
DR   RefSeq; NP_266405.1; NC_002662.1.
DR   RefSeq; WP_010905236.1; NC_002662.1.
DR   PDB; 3CR3; X-ray; 2.10 A; A/B=2-192.
DR   PDBsum; 3CR3; -.
DR   ProteinModelPortal; Q9CIV7; -.
DR   STRING; 272623.L46694; -.
DR   EnsemblBacteria; AAK04347; AAK04347; L46694.
DR   GeneID; 1113859; -.
DR   KEGG; lla:L46694; -.
DR   PATRIC; 22292678; VBILacLac136773_0274.
DR   eggNOG; COG2376; -.
DR   HOGENOM; HOG000226525; -.
DR   KO; K05879; -.
DR   OMA; GENVDRG; -.
DR   OrthoDB; EOG65J57G; -.
DR   BioCyc; LLAC272623:GHSH-272-MONOMER; -.
DR   UniPathway; UPA00616; -.
DR   EvolutionaryTrace; Q9CIV7; -.
DR   Proteomes; UP000002196; Chromosome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004371; F:glycerone kinase activity; IEA:InterPro.
DR   GO; GO:0019563; P:glycerol catabolic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR012737; DhaK_L_YcgS.
DR   InterPro; IPR004007; DhaL_dom.
DR   Pfam; PF02734; Dak2; 1.
DR   SUPFAM; SSF101473; SSF101473; 1.
DR   TIGRFAMs; TIGR02365; dha_L_ycgS; 1.
DR   PROSITE; PS51480; DHAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Glycerol metabolism;
KW   Kinase; Nucleotide-binding; Reference proteome; Transferase.
FT   CHAIN         1    192       PTS-dependent dihydroxyacetone kinase,
FT                                ADP-binding subunit DhaL.
FT                                /FTId=PRO_0000270535.
FT   DOMAIN        5    189       DhaL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00813}.
FT   NP_BIND      34     40       ADP. {ECO:0000269|PubMed:18957416}.
FT   NP_BIND      78     79       ADP. {ECO:0000269|PubMed:18957416}.
FT   NP_BIND     174    176       ADP. {ECO:0000269|PubMed:18957416}.
FT   BINDING     115    115       ADP; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:18957416}.
FT   BINDING     161    161       ADP. {ECO:0000305|PubMed:18957416}.
FT   MUTAGEN     114    114       R->A: Reduces activity 3-fold.
FT                                {ECO:0000269|PubMed:18957416}.
FT   MUTAGEN     114    114       R->E: Reduces activity 100-fold.
FT                                {ECO:0000269|PubMed:18957416}.
FT   MUTAGEN     161    161       R->A: Loss of activity.
FT                                {ECO:0000269|PubMed:18957416}.
FT   MUTAGEN     164    164       Y->A: Reduces activity about 20-fold.
FT                                {ECO:0000269|PubMed:18957416}.
FT   HELIX         4     20       {ECO:0000244|PDB:3CR3}.
FT   HELIX        22     28       {ECO:0000244|PDB:3CR3}.
FT   TURN         29     32       {ECO:0000244|PDB:3CR3}.
FT   HELIX        37     54       {ECO:0000244|PDB:3CR3}.
FT   HELIX        60     74       {ECO:0000244|PDB:3CR3}.
FT   HELIX        79     94       {ECO:0000244|PDB:3CR3}.
FT   HELIX       100    115       {ECO:0000244|PDB:3CR3}.
FT   STRAND      121    123       {ECO:0000244|PDB:3CR3}.
FT   HELIX       125    136       {ECO:0000244|PDB:3CR3}.
FT   HELIX       142    151       {ECO:0000244|PDB:3CR3}.
FT   HELIX       152    154       {ECO:0000244|PDB:3CR3}.
FT   HELIX       161    169       {ECO:0000244|PDB:3CR3}.
FT   HELIX       175    191       {ECO:0000244|PDB:3CR3}.
SQ   SEQUENCE   192 AA;  20578 MW;  7609CBD5D97D1751 CRC64;
     MLTIDTTIEW LGKFNEKIQE NKAYLSELDG PIGDGDHGAN MARGMSETMK ALEVSNFGNV
     SEIFKKVAMT LMSKVGGASG PLYGSAFLAM SKTAIETLDT SELIYAGLEA IQKRGKAQVG
     EKTMVDIWSA FLNDLQTDSA SKDNLEKVVK ASAGLLATKG RASYLGERSI GHIDPGTQSS
     AYLFETLLEV VA
//
